Optimization of a drug simultaneous dissolution and permeability screening method
Autor(a) principal: | |
---|---|
Data de Publicação: | 2008 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://doi.org/10.25758/set.144 |
Resumo: | The goal of this research project was the optimization of a method for simultaneously screening the dissolution rate and the permeability of drug formulations across Polyvinylidene Fluoride membranes, using a bilateral flow cell. Initially, the effect of several variables was tested on caffeine and acetylsalicylic acid permeability. The obtained results showed that the method is more reproducible when the flow cell is used with the unilateral flow at the donor side and with stirring on the acceptor side. It was also showed that the method is able to detect the influence of pH (caffeine Papp at pH 7,4 and 4,5: 4,84±1,57x10-5cm.s-1 and 6,00±0,70x10-5cm.s-1; acetylsalicylic acid Papp at pH 7,4 and 4,5: 3,85±0,38x10-5cm.s-1 and 5,11±0,65x10-5cm.s-1) and excipients (Papp of isolated caffeine and in the presence of excipients: 6,76±1,22x10-5cm.s-1 and 5,84±0,43x10-5cm.s-1; Papp of isolated acetylsalicylic acid and in the presence of excipients: 7,07±1,56 x 10-5cm.s-1 and 5,19±0,23x10-5cm.s-1) in drug permeability. A dissolution medium with pH 4.5, defined in the United States Pharmacopeia (USP) for caffeine/acetylsalicylic acid tablets, was used. Another biorelevant method was developed using a dissolution media with pH 7.4 due to the future goal of testing drug permeability with Caco-2 cellular membranes. The dissolution percentages with this new media were 96,3% for caffeine and 87,1% for acetylsalicylic acid, higher than the 80% minimum limit described by the USP, making it possible to use this media in all the permeability assays. After the establishment of the isolated dissolution and permeability methodologies, the next step was the connection of both techniques. The dissolution/permeability assays were performed with a commercial pharmaceutical form containing both caffeine and acetylsalicylic acid (Melhoral®). The permeability results were reproducible and allowed discrimination between different media, opening therefore the possibility of its application in future works using cellular (Caco-2) or tissue (skin and intestinal) membranes. |
id |
RCAP_52d0d367c3e0510cb552204492bb7bd2 |
---|---|
oai_identifier_str |
oai:journals.ipl.pt:article/762 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Optimization of a drug simultaneous dissolution and permeability screening methodOptimização de um método de avaliação simultânea da dissolução e permeabilidade de fármacosBiodisponibilidadeDissoluçãoPermeabilidadeMétodos in vitroBioavailabilityDissolutionPermeabilityIn vitro methodsThe goal of this research project was the optimization of a method for simultaneously screening the dissolution rate and the permeability of drug formulations across Polyvinylidene Fluoride membranes, using a bilateral flow cell. Initially, the effect of several variables was tested on caffeine and acetylsalicylic acid permeability. The obtained results showed that the method is more reproducible when the flow cell is used with the unilateral flow at the donor side and with stirring on the acceptor side. It was also showed that the method is able to detect the influence of pH (caffeine Papp at pH 7,4 and 4,5: 4,84±1,57x10-5cm.s-1 and 6,00±0,70x10-5cm.s-1; acetylsalicylic acid Papp at pH 7,4 and 4,5: 3,85±0,38x10-5cm.s-1 and 5,11±0,65x10-5cm.s-1) and excipients (Papp of isolated caffeine and in the presence of excipients: 6,76±1,22x10-5cm.s-1 and 5,84±0,43x10-5cm.s-1; Papp of isolated acetylsalicylic acid and in the presence of excipients: 7,07±1,56 x 10-5cm.s-1 and 5,19±0,23x10-5cm.s-1) in drug permeability. A dissolution medium with pH 4.5, defined in the United States Pharmacopeia (USP) for caffeine/acetylsalicylic acid tablets, was used. Another biorelevant method was developed using a dissolution media with pH 7.4 due to the future goal of testing drug permeability with Caco-2 cellular membranes. The dissolution percentages with this new media were 96,3% for caffeine and 87,1% for acetylsalicylic acid, higher than the 80% minimum limit described by the USP, making it possible to use this media in all the permeability assays. After the establishment of the isolated dissolution and permeability methodologies, the next step was the connection of both techniques. The dissolution/permeability assays were performed with a commercial pharmaceutical form containing both caffeine and acetylsalicylic acid (Melhoral®). The permeability results were reproducible and allowed discrimination between different media, opening therefore the possibility of its application in future works using cellular (Caco-2) or tissue (skin and intestinal) membranes. Englobado na temática do desenvolvimento de métodos in vitro para avaliação da biodisponibilidade de fármacos, este trabalho de investigação teve como objectivo a optimização de um método para avaliar em simultâneo a dissolução e permeabilidade de fármacos usando uma célula de fluxo bilateral com membranas de Polyvinylidene Fluoride (PVDF). Através de uma avaliação inicial, na qual se testou o efeito de diversas variáveis na permeabilidade da cafeína e do ácido acetilsalicílico, obtiveram-se resultados que permitiram concluir que os ensaios realizados são mais reprodutíveis, quando a célula de fluxo é utilizada em circulação unilateral no lado dador e com agitação do lado aceitador. Observou-se ainda que o método permite detectar a influência do pH (Papp da cafeína a pH 7,4 e 4,5: 4,84±1,57x10-5cm.s-1 e 6,00±0,70x10-5cm.s-1; Papp do ácido acetilsalicílico a pH 7,4 e 4,5: 3,85±0,38x10-5cm.s-1 e 5,11±0,65x10-5cm.s-1) e dos excipientes (Papp da cafeína isoladamente e em presença de excipientes: 6,76±1,22 x 10-5cm.s-1 e 5,84±0,43x10-5cm.s-1; Papp do ácido acetilsalicílico isoladamente e em presença de excipientes: 7,07±1,56x10-5 cm.s-1 e 5,19±0,23x10-5cm.s-1) na permeabilidade dos compostos. Na avaliação da dissolução testou-se um método descrito na United States Pharmacopeia (USP) com meio de dissolução a pH 4,5 e um método com meio de dissolução a pH 7,4 pois na perspectiva de no futuro se realizarem ensaios com membranas celulares Caco-2, foi necessário testar um meio compatível com estas. As percentagens de dissolução dos ensaios a pH 7,4 foram de 96,3% para a cafeína e de 87,1% para o ácido acetilsalicílico, o que permitiu a utilização deste meio, visto ter sido superior ao limite mínimo de 80% estabelecido pela USP. Após estabelecimento das metodologias de dissolução e permeabilidade individuais, passou-se ao acoplamento das duas técnicas, tendo sido realizados ensaios de dissolução/permeabilidade com uma forma farmacêutica contendo os dois compostos em estudo (Melhoral®), nos quais se obtiveram permeabilidades aparentes de 3,97±0,37x10-5cm.s-1 e 3,69±0,29 x10-5cm.s-1 para a cafeína e ácido acetilsalicílico a pH 4,5 e de 3,77±0,40x10-5cm.s-1 e 4,08± 0,04x10-5cm.s-1 para a cafeína e ácido acetilsalicílico a pH 7,4, resultados estes que foram reprodutíveis e descriminativos e que perspectivam a possibilidade da utilização do sistema para futuros trabalhos envolvendo membranas de culturas celulares (Caco-2) ou tecidos (pele ou intestino).Escola Superior de Tecnologia da Saúde de Lisboa (Instituto Politécnico de Lisboa)2008-11-15info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.25758/set.144https://doi.org/10.25758/set.144Saúde e Tecnologia; No. 02 (2008): Novembro 2008; 38-44Saúde & Tecnologia; N.º 02 (2008): Novembro 2008; 38-441646-9704reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://journals.ipl.pt/stecnologia/article/view/762https://journals.ipl.pt/stecnologia/article/view/762/651Direitos de Autor (c) 2023 Saúde & Tecnologiainfo:eu-repo/semantics/openAccessFerreira, PedroSerra, HugoPedro, João MárioGraça, AnabelaSimplício, Ana Luísa2023-05-12T08:30:27Zoai:journals.ipl.pt:article/762Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:46:05.642976Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Optimization of a drug simultaneous dissolution and permeability screening method Optimização de um método de avaliação simultânea da dissolução e permeabilidade de fármacos |
title |
Optimization of a drug simultaneous dissolution and permeability screening method |
spellingShingle |
Optimization of a drug simultaneous dissolution and permeability screening method Ferreira, Pedro Biodisponibilidade Dissolução Permeabilidade Métodos in vitro Bioavailability Dissolution Permeability In vitro methods |
title_short |
Optimization of a drug simultaneous dissolution and permeability screening method |
title_full |
Optimization of a drug simultaneous dissolution and permeability screening method |
title_fullStr |
Optimization of a drug simultaneous dissolution and permeability screening method |
title_full_unstemmed |
Optimization of a drug simultaneous dissolution and permeability screening method |
title_sort |
Optimization of a drug simultaneous dissolution and permeability screening method |
author |
Ferreira, Pedro |
author_facet |
Ferreira, Pedro Serra, Hugo Pedro, João Mário Graça, Anabela Simplício, Ana Luísa |
author_role |
author |
author2 |
Serra, Hugo Pedro, João Mário Graça, Anabela Simplício, Ana Luísa |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Ferreira, Pedro Serra, Hugo Pedro, João Mário Graça, Anabela Simplício, Ana Luísa |
dc.subject.por.fl_str_mv |
Biodisponibilidade Dissolução Permeabilidade Métodos in vitro Bioavailability Dissolution Permeability In vitro methods |
topic |
Biodisponibilidade Dissolução Permeabilidade Métodos in vitro Bioavailability Dissolution Permeability In vitro methods |
description |
The goal of this research project was the optimization of a method for simultaneously screening the dissolution rate and the permeability of drug formulations across Polyvinylidene Fluoride membranes, using a bilateral flow cell. Initially, the effect of several variables was tested on caffeine and acetylsalicylic acid permeability. The obtained results showed that the method is more reproducible when the flow cell is used with the unilateral flow at the donor side and with stirring on the acceptor side. It was also showed that the method is able to detect the influence of pH (caffeine Papp at pH 7,4 and 4,5: 4,84±1,57x10-5cm.s-1 and 6,00±0,70x10-5cm.s-1; acetylsalicylic acid Papp at pH 7,4 and 4,5: 3,85±0,38x10-5cm.s-1 and 5,11±0,65x10-5cm.s-1) and excipients (Papp of isolated caffeine and in the presence of excipients: 6,76±1,22x10-5cm.s-1 and 5,84±0,43x10-5cm.s-1; Papp of isolated acetylsalicylic acid and in the presence of excipients: 7,07±1,56 x 10-5cm.s-1 and 5,19±0,23x10-5cm.s-1) in drug permeability. A dissolution medium with pH 4.5, defined in the United States Pharmacopeia (USP) for caffeine/acetylsalicylic acid tablets, was used. Another biorelevant method was developed using a dissolution media with pH 7.4 due to the future goal of testing drug permeability with Caco-2 cellular membranes. The dissolution percentages with this new media were 96,3% for caffeine and 87,1% for acetylsalicylic acid, higher than the 80% minimum limit described by the USP, making it possible to use this media in all the permeability assays. After the establishment of the isolated dissolution and permeability methodologies, the next step was the connection of both techniques. The dissolution/permeability assays were performed with a commercial pharmaceutical form containing both caffeine and acetylsalicylic acid (Melhoral®). The permeability results were reproducible and allowed discrimination between different media, opening therefore the possibility of its application in future works using cellular (Caco-2) or tissue (skin and intestinal) membranes. |
publishDate |
2008 |
dc.date.none.fl_str_mv |
2008-11-15 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.25758/set.144 https://doi.org/10.25758/set.144 |
url |
https://doi.org/10.25758/set.144 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://journals.ipl.pt/stecnologia/article/view/762 https://journals.ipl.pt/stecnologia/article/view/762/651 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2023 Saúde & Tecnologia info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2023 Saúde & Tecnologia |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Escola Superior de Tecnologia da Saúde de Lisboa (Instituto Politécnico de Lisboa) |
publisher.none.fl_str_mv |
Escola Superior de Tecnologia da Saúde de Lisboa (Instituto Politécnico de Lisboa) |
dc.source.none.fl_str_mv |
Saúde e Tecnologia; No. 02 (2008): Novembro 2008; 38-44 Saúde & Tecnologia; N.º 02 (2008): Novembro 2008; 38-44 1646-9704 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799131544383651840 |